Isotretinoin REMS Still Needed, But Its Burden Could Be Reduced, FDA Staff Says

(MedPage Today) -- A risk evaluation and mitigation strategy (REMS) for the use of isotretinoin to treat severe acne is still very much needed, but there are ways to lighten its burden on patients and providers, according to FDA staff. For example...
Source: MedPage Today Public Health - Category: American Health Source Type: news